Le SIDA au Ghana (serveur d'exploration)

Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.

Strongly enhanced sensitivity of a direct anti-HIV-1/-2 assay in seroconversion by incorporation of HIV p24 ag detection: a new generation vironostika HIV Uni-Form II

Identifieur interne : 001239 ( Main/Exploration ); précédent : 001238; suivant : 001240

Strongly enhanced sensitivity of a direct anti-HIV-1/-2 assay in seroconversion by incorporation of HIV p24 ag detection: a new generation vironostika HIV Uni-Form II

Auteurs : J. Van Binsbergen [Pays-Bas] ; W. Keur [Pays-Bas] ; A. Siebelink [Pays-Bas] ; M. Van De Graaf [Pays-Bas] ; A. Jacobs [Pays-Bas] ; D. De Rijk [Pays-Bas] ; L. Nijholt [Pays-Bas] ; J. Toonen [Pays-Bas] ; L. G. Gürtler [Allemagne]

Source :

RBID : ISTEX:67C1AA832CBDE8DE66B211BFAE101DA16D583A07

Descripteurs français

English descriptors

Abstract

The clinical sensitivity of the current anti-HIV assays is based for an important part on their reactivity with seroconversion panels. The most sensitive assay closes the seroconversion window as much as possible, thereby reducing the risk of transmitting false negative donations obtained from individuals infected recently. Because of the absence of anti-HIV antibodies during the early phase of infection, the seroconversion window can be narrowed partially by detection of HIV p24 Ag. To achieve this, the highest affinity anti-p24 binding antibodies were selected with BIAcore™ and applied in a direct assay format. To achieve optimal conditions for the anti-HIV part of the assay the HIV specific antigens viral HIV-1 gp160, HIV-2 gp36 and HIV-1 group O gp41 peptides were used. These antigens and antibodies were applied for microELISA coating as well as in the conjugate pearl, which is present in the well of the microELISA plate. The (analytical) anti-HIV-1/-2 and anti-HIV-1 group O sensitivity of this new assay, Vironostika HIV Uni-Form II Ag/Ab, is at least at the level of the current Vironostika HIV Uni-Form II plus O. When compared to the Vironostika HIV Uni-Form II plus O, the seroconversion window is narrowed by 1–2 weeks due to the incorporation of HIV p24 Ag detection. The level of reactivity of the anti-HIV and HIV Ag detection part can be improved by about a factor 2 by applying continuous shaking during sample incubation. Initial studies suggested that the specificity of the assay is identical to that of the Vironostika HIV Uni-Form II plus O, namely >99.9%. Monitoring of proper execution of the assay handling steps was facilitated by implementing a purple dye in the conjugate pearl. Colourless specimen diluent changes into a green fluid upon dissolving of the conjugate pearl and turns subsequently into blue/purple upon sample addition. These visual changes can also be determined by spectrophotometric measurement at 620 nm.

Url:
DOI: 10.1016/S0166-0934(98)00126-8


Affiliations:


Links toward previous steps (curation, corpus...)


Le document en format XML

<record>
<TEI wicri:istexFullTextTei="biblStruct">
<teiHeader>
<fileDesc>
<titleStmt>
<title xml:lang="en">Strongly enhanced sensitivity of a direct anti-HIV-1/-2 assay in seroconversion by incorporation of HIV p24 ag detection: a new generation vironostika HIV Uni-Form II</title>
<author>
<name sortKey="Van Binsbergen, J" sort="Van Binsbergen, J" uniqKey="Van Binsbergen J" first="J." last="Van Binsbergen">J. Van Binsbergen</name>
</author>
<author>
<name sortKey="Keur, W" sort="Keur, W" uniqKey="Keur W" first="W." last="Keur">W. Keur</name>
</author>
<author>
<name sortKey="Siebelink, A" sort="Siebelink, A" uniqKey="Siebelink A" first="A." last="Siebelink">A. Siebelink</name>
</author>
<author>
<name sortKey="Van De Graaf, M" sort="Van De Graaf, M" uniqKey="Van De Graaf M" first="M." last="Van De Graaf">M. Van De Graaf</name>
</author>
<author>
<name sortKey="Jacobs, A" sort="Jacobs, A" uniqKey="Jacobs A" first="A." last="Jacobs">A. Jacobs</name>
</author>
<author>
<name sortKey="De Rijk, D" sort="De Rijk, D" uniqKey="De Rijk D" first="D." last="De Rijk">D. De Rijk</name>
</author>
<author>
<name sortKey="Nijholt, L" sort="Nijholt, L" uniqKey="Nijholt L" first="L." last="Nijholt">L. Nijholt</name>
</author>
<author>
<name sortKey="Toonen, J" sort="Toonen, J" uniqKey="Toonen J" first="J." last="Toonen">J. Toonen</name>
</author>
<author>
<name sortKey="Gurtler, L G" sort="Gurtler, L G" uniqKey="Gurtler L" first="L. G." last="Gürtler">L. G. Gürtler</name>
</author>
</titleStmt>
<publicationStmt>
<idno type="wicri:source">ISTEX</idno>
<idno type="RBID">ISTEX:67C1AA832CBDE8DE66B211BFAE101DA16D583A07</idno>
<date when="1998" year="1998">1998</date>
<idno type="doi">10.1016/S0166-0934(98)00126-8</idno>
<idno type="url">https://api.istex.fr/document/67C1AA832CBDE8DE66B211BFAE101DA16D583A07/fulltext/pdf</idno>
<idno type="wicri:Area/Istex/Corpus">000033</idno>
<idno type="wicri:explorRef" wicri:stream="Istex" wicri:step="Corpus" wicri:corpus="ISTEX">000033</idno>
<idno type="wicri:Area/Istex/Curation">000033</idno>
<idno type="wicri:Area/Istex/Checkpoint">000733</idno>
<idno type="wicri:explorRef" wicri:stream="Istex" wicri:step="Checkpoint">000733</idno>
<idno type="wicri:doubleKey">0166-0934:1998:Van Binsbergen J:strongly:enhanced:sensitivity</idno>
<idno type="wicri:Area/Main/Merge">001336</idno>
<idno type="wicri:Area/Main/Curation">001239</idno>
<idno type="wicri:Area/Main/Exploration">001239</idno>
</publicationStmt>
<sourceDesc>
<biblStruct>
<analytic>
<title level="a" type="main" xml:lang="en">Strongly enhanced sensitivity of a direct anti-HIV-1/-2 assay in seroconversion by incorporation of HIV p24 ag detection: a new generation vironostika HIV Uni-Form II</title>
<author>
<name sortKey="Van Binsbergen, J" sort="Van Binsbergen, J" uniqKey="Van Binsbergen J" first="J." last="Van Binsbergen">J. Van Binsbergen</name>
<affiliation wicri:level="1">
<country xml:lang="fr">Pays-Bas</country>
<wicri:regionArea>Organon Teknika, Boseind 15, 5281 RM, Boxtel</wicri:regionArea>
<wicri:noRegion>Boxtel</wicri:noRegion>
</affiliation>
</author>
<author>
<name sortKey="Keur, W" sort="Keur, W" uniqKey="Keur W" first="W." last="Keur">W. Keur</name>
<affiliation wicri:level="1">
<country xml:lang="fr">Pays-Bas</country>
<wicri:regionArea>Organon Teknika, Boseind 15, 5281 RM, Boxtel</wicri:regionArea>
<wicri:noRegion>Boxtel</wicri:noRegion>
</affiliation>
</author>
<author>
<name sortKey="Siebelink, A" sort="Siebelink, A" uniqKey="Siebelink A" first="A." last="Siebelink">A. Siebelink</name>
<affiliation wicri:level="1">
<country xml:lang="fr">Pays-Bas</country>
<wicri:regionArea>Organon Teknika, Boseind 15, 5281 RM, Boxtel</wicri:regionArea>
<wicri:noRegion>Boxtel</wicri:noRegion>
</affiliation>
</author>
<author>
<name sortKey="Van De Graaf, M" sort="Van De Graaf, M" uniqKey="Van De Graaf M" first="M." last="Van De Graaf">M. Van De Graaf</name>
<affiliation wicri:level="1">
<country xml:lang="fr">Pays-Bas</country>
<wicri:regionArea>Organon Teknika, Boseind 15, 5281 RM, Boxtel</wicri:regionArea>
<wicri:noRegion>Boxtel</wicri:noRegion>
</affiliation>
</author>
<author>
<name sortKey="Jacobs, A" sort="Jacobs, A" uniqKey="Jacobs A" first="A." last="Jacobs">A. Jacobs</name>
<affiliation wicri:level="1">
<country xml:lang="fr">Pays-Bas</country>
<wicri:regionArea>Organon Teknika, Boseind 15, 5281 RM, Boxtel</wicri:regionArea>
<wicri:noRegion>Boxtel</wicri:noRegion>
</affiliation>
</author>
<author>
<name sortKey="De Rijk, D" sort="De Rijk, D" uniqKey="De Rijk D" first="D." last="De Rijk">D. De Rijk</name>
<affiliation wicri:level="1">
<country xml:lang="fr">Pays-Bas</country>
<wicri:regionArea>Organon Teknika, Boseind 15, 5281 RM, Boxtel</wicri:regionArea>
<wicri:noRegion>Boxtel</wicri:noRegion>
</affiliation>
</author>
<author>
<name sortKey="Nijholt, L" sort="Nijholt, L" uniqKey="Nijholt L" first="L." last="Nijholt">L. Nijholt</name>
<affiliation wicri:level="1">
<country xml:lang="fr">Pays-Bas</country>
<wicri:regionArea>Organon Teknika, Boseind 15, 5281 RM, Boxtel</wicri:regionArea>
<wicri:noRegion>Boxtel</wicri:noRegion>
</affiliation>
</author>
<author>
<name sortKey="Toonen, J" sort="Toonen, J" uniqKey="Toonen J" first="J." last="Toonen">J. Toonen</name>
<affiliation wicri:level="1">
<country xml:lang="fr">Pays-Bas</country>
<wicri:regionArea>Organon Teknika, Boseind 15, 5281 RM, Boxtel</wicri:regionArea>
<wicri:noRegion>Boxtel</wicri:noRegion>
</affiliation>
</author>
<author>
<name sortKey="Gurtler, L G" sort="Gurtler, L G" uniqKey="Gurtler L" first="L. G." last="Gürtler">L. G. Gürtler</name>
<affiliation wicri:level="4">
<country xml:lang="fr">Allemagne</country>
<wicri:regionArea>Max von Pettenkofer Institut, Universität München, D-80336, München</wicri:regionArea>
<placeName>
<region type="land" nuts="1">Bavière</region>
<region type="district" nuts="2">District de Haute-Bavière</region>
<settlement type="city">Munich</settlement>
</placeName>
<orgName type="university">Université Louis-et-Maximilien de Munich</orgName>
</affiliation>
</author>
</analytic>
<monogr></monogr>
<series>
<title level="j">Journal of Virological Methods</title>
<title level="j" type="abbrev">VIRMET</title>
<idno type="ISSN">0166-0934</idno>
<imprint>
<publisher>ELSEVIER</publisher>
<date type="published" when="1998">1998</date>
<biblScope unit="volume">76</biblScope>
<biblScope unit="issue">1–2</biblScope>
<biblScope unit="page" from="59">59</biblScope>
<biblScope unit="page" to="71">71</biblScope>
</imprint>
<idno type="ISSN">0166-0934</idno>
</series>
</biblStruct>
</sourceDesc>
<seriesStmt>
<idno type="ISSN">0166-0934</idno>
</seriesStmt>
</fileDesc>
<profileDesc>
<textClass>
<keywords scheme="KwdEn" xml:lang="en">
<term>AIDS</term>
<term>Antibody</term>
<term>Antibody titer</term>
<term>Antigen detection</term>
<term>Assay</term>
<term>BIA, biomolecular interaction analysis</term>
<term>Binsbergen</term>
<term>Blood bank</term>
<term>COV, cut off value</term>
<term>Clinical sensitivity</term>
<term>Combined HIV antibody and antigen detection</term>
<term>Conjugate pearl</term>
<term>Current assays</term>
<term>Current vironostika</term>
<term>Detection limit</term>
<term>Detection part</term>
<term>Different vironostika</term>
<term>Dilution series</term>
<term>Direct assay</term>
<term>Direct assay format</term>
<term>EDC, N-(3-dimethylaminopropyl)-N′-ethylcarbodiimide hydrochloride</term>
<term>EIA, enzyme immuno assay</term>
<term>Elsevier science</term>
<term>Generation vironostika</term>
<term>Ghana</term>
<term>HIV</term>
<term>HIV, human immunodeficiency virus</term>
<term>HRP, horseradish peroxidase</term>
<term>Hama</term>
<term>Heat treatment</term>
<term>Horseradish peroxidase</term>
<term>Human virus</term>
<term>ICD, immunecomplex dissociation</term>
<term>Ig, immunoglobulin</term>
<term>Immunecomplex dissociation</term>
<term>MCA, monoclonal antibody</term>
<term>Microelisa</term>
<term>Microelisa plate</term>
<term>Monoclonal</term>
<term>Monoclonal antibodies</term>
<term>NHS, N-hydroxysuccinimide</term>
<term>Organon teknika</term>
<term>Other samples</term>
<term>Peptide</term>
<term>Positive reaction</term>
<term>Positive samples</term>
<term>Reactive</term>
<term>Reactive samples</term>
<term>Results show</term>
<term>S, sample</term>
<term>SPDP, N-succinimidyl 3-(2-pyridyldithio) propionate</term>
<term>SPR, surface plasmon resonance</term>
<term>Sample addition</term>
<term>Sample incubation</term>
<term>Second measurement</term>
<term>Seroconversion</term>
<term>Seroconversion panels</term>
<term>Seroconversion window</term>
<term>Seroconversion window period</term>
<term>Specimen diluent</term>
<term>Surface plasmon resonance</term>
<term>TMB, tetramethylbenzidine</term>
<term>Third generation assay</term>
<term>Titer performance panel</term>
<term>UP, ureaperoxide</term>
<term>Viral</term>
<term>Virological</term>
<term>Virological methods</term>
<term>Vironostika</term>
<term>Western blot</term>
<term>Window phase</term>
<term>p24</term>
</keywords>
<keywords scheme="Teeft" xml:lang="en">
<term>Antibody</term>
<term>Antibody titer</term>
<term>Antigen detection</term>
<term>Assay</term>
<term>Binsbergen</term>
<term>Blood bank</term>
<term>Clinical sensitivity</term>
<term>Conjugate pearl</term>
<term>Current assays</term>
<term>Current vironostika</term>
<term>Detection limit</term>
<term>Detection part</term>
<term>Different vironostika</term>
<term>Dilution series</term>
<term>Direct assay</term>
<term>Direct assay format</term>
<term>Elsevier science</term>
<term>Generation vironostika</term>
<term>Ghana</term>
<term>Hama</term>
<term>Heat treatment</term>
<term>Horseradish peroxidase</term>
<term>Human virus</term>
<term>Immunecomplex dissociation</term>
<term>Microelisa</term>
<term>Microelisa plate</term>
<term>Monoclonal</term>
<term>Monoclonal antibodies</term>
<term>Organon teknika</term>
<term>Other samples</term>
<term>Peptide</term>
<term>Positive reaction</term>
<term>Positive samples</term>
<term>Reactive</term>
<term>Reactive samples</term>
<term>Results show</term>
<term>Sample addition</term>
<term>Sample incubation</term>
<term>Second measurement</term>
<term>Seroconversion</term>
<term>Seroconversion panels</term>
<term>Seroconversion window</term>
<term>Seroconversion window period</term>
<term>Specimen diluent</term>
<term>Surface plasmon resonance</term>
<term>Third generation assay</term>
<term>Titer performance panel</term>
<term>Viral</term>
<term>Virological</term>
<term>Virological methods</term>
<term>Vironostika</term>
<term>Western blot</term>
<term>Window phase</term>
</keywords>
<keywords scheme="Wicri" type="geographic" xml:lang="fr">
<term>Ghana</term>
</keywords>
<keywords scheme="Wicri" type="topic" xml:lang="fr">
<term>Sida</term>
</keywords>
</textClass>
<langUsage>
<language ident="en">en</language>
</langUsage>
</profileDesc>
</teiHeader>
<front>
<div type="abstract" xml:lang="en">The clinical sensitivity of the current anti-HIV assays is based for an important part on their reactivity with seroconversion panels. The most sensitive assay closes the seroconversion window as much as possible, thereby reducing the risk of transmitting false negative donations obtained from individuals infected recently. Because of the absence of anti-HIV antibodies during the early phase of infection, the seroconversion window can be narrowed partially by detection of HIV p24 Ag. To achieve this, the highest affinity anti-p24 binding antibodies were selected with BIAcore™ and applied in a direct assay format. To achieve optimal conditions for the anti-HIV part of the assay the HIV specific antigens viral HIV-1 gp160, HIV-2 gp36 and HIV-1 group O gp41 peptides were used. These antigens and antibodies were applied for microELISA coating as well as in the conjugate pearl, which is present in the well of the microELISA plate. The (analytical) anti-HIV-1/-2 and anti-HIV-1 group O sensitivity of this new assay, Vironostika HIV Uni-Form II Ag/Ab, is at least at the level of the current Vironostika HIV Uni-Form II plus O. When compared to the Vironostika HIV Uni-Form II plus O, the seroconversion window is narrowed by 1–2 weeks due to the incorporation of HIV p24 Ag detection. The level of reactivity of the anti-HIV and HIV Ag detection part can be improved by about a factor 2 by applying continuous shaking during sample incubation. Initial studies suggested that the specificity of the assay is identical to that of the Vironostika HIV Uni-Form II plus O, namely >99.9%. Monitoring of proper execution of the assay handling steps was facilitated by implementing a purple dye in the conjugate pearl. Colourless specimen diluent changes into a green fluid upon dissolving of the conjugate pearl and turns subsequently into blue/purple upon sample addition. These visual changes can also be determined by spectrophotometric measurement at 620 nm.</div>
</front>
</TEI>
<affiliations>
<list>
<country>
<li>Allemagne</li>
<li>Pays-Bas</li>
</country>
<region>
<li>Bavière</li>
<li>District de Haute-Bavière</li>
</region>
<settlement>
<li>Munich</li>
</settlement>
<orgName>
<li>Université Louis-et-Maximilien de Munich</li>
</orgName>
</list>
<tree>
<country name="Pays-Bas">
<noRegion>
<name sortKey="Van Binsbergen, J" sort="Van Binsbergen, J" uniqKey="Van Binsbergen J" first="J." last="Van Binsbergen">J. Van Binsbergen</name>
</noRegion>
<name sortKey="De Rijk, D" sort="De Rijk, D" uniqKey="De Rijk D" first="D." last="De Rijk">D. De Rijk</name>
<name sortKey="Jacobs, A" sort="Jacobs, A" uniqKey="Jacobs A" first="A." last="Jacobs">A. Jacobs</name>
<name sortKey="Keur, W" sort="Keur, W" uniqKey="Keur W" first="W." last="Keur">W. Keur</name>
<name sortKey="Nijholt, L" sort="Nijholt, L" uniqKey="Nijholt L" first="L." last="Nijholt">L. Nijholt</name>
<name sortKey="Siebelink, A" sort="Siebelink, A" uniqKey="Siebelink A" first="A." last="Siebelink">A. Siebelink</name>
<name sortKey="Toonen, J" sort="Toonen, J" uniqKey="Toonen J" first="J." last="Toonen">J. Toonen</name>
<name sortKey="Van De Graaf, M" sort="Van De Graaf, M" uniqKey="Van De Graaf M" first="M." last="Van De Graaf">M. Van De Graaf</name>
</country>
<country name="Allemagne">
<region name="Bavière">
<name sortKey="Gurtler, L G" sort="Gurtler, L G" uniqKey="Gurtler L" first="L. G." last="Gürtler">L. G. Gürtler</name>
</region>
</country>
</tree>
</affiliations>
</record>

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Wicri/Sante/explor/SidaGhanaV1/Data/Main/Exploration
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 001239 | SxmlIndent | more

Ou

HfdSelect -h $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd -nk 001239 | SxmlIndent | more

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Wicri/Sante
   |area=    SidaGhanaV1
   |flux=    Main
   |étape=   Exploration
   |type=    RBID
   |clé=     ISTEX:67C1AA832CBDE8DE66B211BFAE101DA16D583A07
   |texte=   Strongly enhanced sensitivity of a direct anti-HIV-1/-2 assay in seroconversion by incorporation of HIV p24 ag detection: a new generation vironostika HIV Uni-Form II
}}

Wicri

This area was generated with Dilib version V0.6.31.
Data generation: Tue Nov 7 18:07:38 2017. Site generation: Tue Mar 5 15:01:57 2024